Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Sources
sec edgar · verbatim disclosureEach tie, with the sentence that disclosed it. Open a row for the wording and the filing it came from.
“In April 2018, we entered into a development and license agreement (the "CMCC Agreement") with Children's Medical Center Corporation ("CMCC").”
FILING10-K0001736730-26-000016cik 0001736730
“In addition, certain of the raw materials for our product candidates are currently provided by a Chinese company, Hongene Biotech, and we expect to rely on this supplier for the foreseeable future on an as-needed basis.”
FILING10-K0001736730-26-000016cik 0001736730
“In connection with the filing of the Shelf Registration Statement, we also entered into a sales agreement (the "Sales Agreement") with Leerink Partners LLC, as sales agent, pursuant to which we may issue and sell shares of our common stock for a maximum aggregate offering price of up to $100.0 million, which is included in the $300.0 million of securities that may be offered pursuant to the Shelf Registration Statement.”
FILING10-K0001736730-26-000016cik 0001736730
“For example, we rely on a license from the Whitehead Institute for Biomedical Research.”
FILING10-K0001736730-26-000016cik 0001736730
“Under the terms of the BioMarin Agreement, BioMarin paid us an upfront, nonrefundable payment of $1.0 million, and reimbursed us for certain research activities.”
FILING10-K0001736730-26-000016cik 0001736730
“During the years ended December 31, 2025 and 2024, we recorded $0.1 million and $0.5 million, respectively, as a reduction in R&D expense in the consolidated statement of operations and comprehensive loss as a result of the earned R&D reimbursement from Eli Lilly.”
FILING10-K0001736730-26-000016cik 0001736730
“In exchange for the license rights, Fulcrum paid us a $0.4 million upfront payment.”
FILING10-K0001736730-26-000016cik 0001736730
“Under the terms of this agreement, we granted GSK an exclusive, worldwide license under certain patents and know-how to research, develop, manufacture and commercialize certain compounds and products directed to the Collaboration Targets.”
FILING10-K0001736730-26-000016cik 0001736730
Watchlist prices, news filtered to it, and its next report on your desk.
Camp4 Therapeutics Corp has 4 disclosed suppliers and 4 disclosed customers. Each one is named in an SEC filing, either Camp4 Therapeutics Corp’s own annual report or the counterparty’s, and carries the sentence that discloses it.
Camp4 Therapeutics Corp
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
Prev close 4.14 · gapped above the open, then crossed back over prior close. High/low 4.21 at 9:30 am ET, 4.07 at 3:30 pm ET.
CAMP (Camp4 Therapeutics Corp) has 4 disclosed suppliers and 4 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: GSK +0.76%, in industrials & materials.